Psychometric properties of the GAD-7 and PROMIS-Anxiety-4a among youth with depression and suicidality: Results from the Texas youth depression and suicide research network
- PMID: 38169247
- DOI: 10.1016/j.jpsychires.2023.12.033
Psychometric properties of the GAD-7 and PROMIS-Anxiety-4a among youth with depression and suicidality: Results from the Texas youth depression and suicide research network
Abstract
There is a tremendous need for brief, valid, and free assessments of anxiety in child mental healthcare. The goal of this study was to determine the psychometric properties of two such measures, the GAD-7 and PROMIS-Anxiety-4a, in 1000 children, adolescents, and young adults (8-20 years-old) with depression and/or suicidality. The GAD-7, the PROMIS-Anxiety-4a, and other validated assessments of anxiety, physical functioning, and psychiatric diagnoses were completed. Confirmatory factor analyses showed an acceptable fit for a single factor in both measures via all indices but the RMSEA. They demonstrated measurement invariance across pre-adolescents (8-12 years-old) and adolescents and emerging adults (13-20 years-old), though scalar invariance was not observed for the GAD-7. Both measures showed strong convergent validity, GAD-7: r = 0.68; PROMIS-Anxiety-4a: r = 0.75, divergent validity with a measure of physical function, GAD-7: r = -0.24; PROMIS-Anxiety-4a: r = -0.28, good internal consistency, ω = 0.89 for both, and high test-retest reliability, GAD-7: r = 0.69; PROMIS-Anxiety-4a: r = 0.71. Both measures also showed acceptable sensitivity and specificity in detecting the presence of any anxiety disorder, GAD-7 cut-off score of 10: AUC = 0.75; PROMIS-Anxiety-4a cutoff score of 12: AUC = 0.79. The GAD-7 correlated similarly with the Screen for Child Anxiety Related Disorders total score and generalized anxiety subscale, and also showed similar diagnostic sensitivity and specificity when used to detect the presence of any anxiety disorder vs. generalized anxiety disorder specifically. Results suggest that both of these brief, publicly available instruments are valid and reliable assessments of anxiety among youth in treatment for depression and/or suicidality.
Keywords: Adolescents; Children; Generalized anxiety disorder; Major depressive disorder; Reliability; TX-YDSRN.
Copyright © 2023. Published by Elsevier Ltd.
Conflict of interest statement
Declaration of competing interest Dr. Guzick receives research support from the Misophonia Research Fund. Dr. Storch reports receiving research funding to his institution from the Ream Foundation, International OCD Foundation, and NIH. He was a consultant for Brainsway and Biohaven Pharmaceuticals in the past 12 months. He owns stock less than $5000 in NView. He receives book royalties from Elsevier, Wiley, Oxford, American Psychological Association, Guildford, Springer, and Jessica Kingsley. Dr. Trivedi has provided consulting services to Alkermes Inc, Axsome Therapeutics, Biogen MA Inc., Cerebral Inc., Circular Genomics Inc, Compass Pathfinder Limited, GH Research Limited, Heading Health Inc, Janssen, Legion Health Inc, Merck Sharp & Dohme Corp., Mind Medicine (MindMed) Inc, Merck Sharp & Dhome LLC, Naki Health, Ltd., Neurocrine Biosciences Inc, Noema Pharma AG, Orexo US Inc, Otsuka American Pharmaceutical Inc, Otsuka Canada Pharmaceutical Inc, Otsuka Pharmaceutical Development & Commercialization Inc, Praxis Precision Medicines Inc, SAGE Therapeutics, Sparian Biosciences Inc, Takeda Pharmaceutical Company Ltd, WebMD. He sits on the Scientific Advisory Board of Alto Neuroscience Inc, Cerebral Inc., Compass Pathfinder Limited, Heading Health, GreenLight VitalSign6 Inc, Legion Health Inc, Merck Sharp & Dohme Corp, Orexo US Inc, Signant Health. He holds stock in Alto Neuroscience Inc, Cerebral Inc, Circular Genomics Inc, GreenLight VitalSign6 Inc, Legion Health Inc. Additionally, he has received editorial compensation from American Psychiatric Association, and Oxford University Press. All other authors have no disclosures. No other authors report any competing interests.
Similar articles
-
Psychometric properties of the patient health questionnaire-8 and general anxiety disorder-7 in adolescents and young adults from three Latin American cities: Internal structure, invariance, internal consistency and divergent validity.J Affect Disord. 2025 Jun 1;378:138-146. doi: 10.1016/j.jad.2025.02.088. Epub 2025 Feb 26. J Affect Disord. 2025. PMID: 40021062
-
Psychometric properties of Concise Associated Symptom Tracking (CAST) scale in youths and young adults: Findings from the Texas youth depression and suicide research network (TX-YDSRN).J Psychiatr Res. 2023 May;161:179-187. doi: 10.1016/j.jpsychires.2023.03.020. Epub 2023 Mar 13. J Psychiatr Res. 2023. PMID: 36933444
-
Validity of the Generalized Anxiety Disorder-7 scale in an acute psychiatric sample.Clin Psychol Psychother. 2013 Sep-Oct;20(5):456-64. doi: 10.1002/cpp.1802. Epub 2012 May 17. Clin Psychol Psychother. 2013. PMID: 22593009
-
Validation of brief screening measures for depression and anxiety in young people with substance use disorders.J Affect Disord. 2021 Mar 1;282:1021-1029. doi: 10.1016/j.jad.2021.01.005. Epub 2021 Jan 7. J Affect Disord. 2021. PMID: 33601674 Free PMC article.
-
Reliability and validity of the Patient Health Questionnaire-4 scale and its subscales of depression and anxiety among US adults based on nativity.BMC Psychiatry. 2024 Mar 18;24(1):213. doi: 10.1186/s12888-024-05665-8. BMC Psychiatry. 2024. PMID: 38500115 Free PMC article.
Cited by
-
Psychometric validation of the Arabic version of the GAD-7 among Lebanese adolescents.PLoS One. 2025 Aug 5;20(8):e0329627. doi: 10.1371/journal.pone.0329627. eCollection 2025. PLoS One. 2025. PMID: 40763187 Free PMC article.
-
UK Medical Cannabis Registry: A Clinical Outcomes Analysis for Epilepsy.Brain Behav. 2025 Apr;15(4):e70490. doi: 10.1002/brb3.70490. Brain Behav. 2025. PMID: 40249168 Free PMC article.
-
The relationships between body weight, appetite, depression, and anxiety: Findings from the Texas Youth Depression and Suicide Research Network (TX-YDSRN).Health Psychol Open. 2025 Jul 6;12:20551029251359056. doi: 10.1177/20551029251359056. eCollection 2025 Jan-Dec. Health Psychol Open. 2025. PMID: 40630644 Free PMC article.
-
Network analysis in depressed adolescents with suicidal ideation: the role of depression, anxiety, and childhood abuse.Front Psychiatry. 2025 Aug 8;16:1645303. doi: 10.3389/fpsyt.2025.1645303. eCollection 2025. Front Psychiatry. 2025. PMID: 40859933 Free PMC article.
MeSH terms
LinkOut - more resources
Full Text Sources
Medical